BSE Live
Feb 09, 13:02Prev. Close
518.25
Open Price
522.05
Bid Price (Qty.)
530.10 (1)
Offer Price (Qty.)
532.65 (13)
NSE Live
Feb 09, 13:02Prev. Close
519.75
Open Price
525.05
Bid Price (Qty.)
530.80 (14)
Offer Price (Qty.)
531.80 (8)
| Cash Flow of Rossari Biotech (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | |
| 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 88.06 | 63.39 | 37.47 | |
| Net CashFlow From Operating Activities | 56.83 | 71.18 | 25.57 | |
| Net Cash Used In Investing Activities | -190.30 | -36.42 | -20.44 | |
| Net Cash Used From Financing Activities | 156.94 | -29.15 | -6.50 | |
| Foreign Exchange Gains / Losses | 0.00 | -0.49 | -0.15 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 23.47 | 5.12 | -1.51 | |
| Cash And Cash Equivalents Begin of Year | 5.74 | 0.63 | 2.14 | |
| Cash And Cash Equivalents End Of Year | 29.21 | 5.74 | 0.63 |
20.01.2026
Rossari Consolidated December 2025 Net Sales at Rs 581.68 crore, up 13.45% Y-o-Y
19.01.2026
Rossari Standalone December 2025 Net Sales at Rs 450.66 crore, up 22.37% Y-o-Y
16.10.2025
Rossari Consolidated September 2025 Net Sales at Rs 586.11 crore, up 17.61% Y-o-Y
16.10.2025
Rossari Standalone September 2025 Net Sales at Rs 419.51 crore, up 24.86% Y-o-Y